Tchaikapharma High Quality Medicines AD (BUL:THQM)

Bulgaria flag Bulgaria · Delayed Price · Currency is BGN
17.00
-0.10 (-0.58%)
At close: Jun 6, 2025
-1.16%
Market Cap 1.56B
Revenue (ttm) 55.97M
Net Income (ttm) 5.19M
Shares Out 91.80M
EPS (ttm) 0.06
PE Ratio 300.64
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 92
Average Volume 501
Open 15.00
Previous Close 17.10
Day's Range 15.00 - 17.00
52-Week Range 8.10 - 18.00
Beta 0.04
RSI 52.53
Earnings Date Jul 28, 2025

About BUL:THQM

Tchaikapharma High Quality Medicines AD engages in the development and manufacture of generic and in-licensed medicines in Bulgaria. The company offers anaesthetic, anti-inflammatory and anti-rheumatic, antibiotic, cardiovascular system, digestive system, diabetes and metabolism, nervous system, OTC, respiratory system, oncology, and other medicines. The company was founded in 1999 and is headquartered in Sofia, Bulgaria. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 207
Stock Exchange Bulgarian Stock Exchange
Ticker Symbol THQM
Full Company Profile

Financial Performance

In 2024, BUL:THQM's revenue was 53.14 million, an increase of 9.54% compared to the previous year's 48.51 million. Earnings were 4.49 million, an increase of 32.12%.

Financial Statements

News

There is no news available yet.